Anti-tumor necrosis factor therapy is tolerated in an individual with homozygous complement C2 deficiency.

Authors

M. Momeni
A. Mehta
J.D. Katz

Document Type

Journal Article

Publication Date

2005

Journal

Journal of Clinical Rheumatology

Volume

11

Issue

3

Inclusive Pages

180-182

Keywords

Medicine

APA Citation

Momeni, M., Mehta, A., & Katz, J. (2005). Anti-tumor necrosis factor therapy is tolerated in an individual with homozygous complement C2 deficiency.. Journal of Clinical Rheumatology, 11 (3). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs/2151